Financial reports
10-K
2023 FY
Annual report
13 Mar 24
NT 10-K
Notice of late annual filing
1 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
NT 10-Q
Notice of late quarterly filing
13 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
Current reports
8-K
Cytek® Biosciences Names William McCombe Chief Financial Officer
19 Mar 24
8-K
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
1 Mar 24
8-K
Departure of Directors or Certain Officers
27 Feb 24
8-K
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
9 Jan 24
8-K
Regulation FD Disclosure
28 Nov 23
8-K
Q3 2023 Earnings Call
9 Nov 23
8-K
Cytek Biosciences Reports Third Quarter 2023 Financial Results
7 Nov 23
8-K
Cytek Biosciences Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K/A
Financial Statements and Exhibits
15 May 23
Registration and prospectus
S-8
Registration of securities for employees
14 Mar 24
S-8
Registration of securities for employees
1 Mar 23
S-3ASR
Automatic shelf registration
26 Aug 22
S-8
Registration of securities for employees
17 Mar 22
S-8
Registration of securities for employees
23 Jul 21
424B4
Prospectus supplement with pricing info
23 Jul 21
8-A12B
Registration of securities on exchange
19 Jul 21
S-1/A
IPO registration (amended)
19 Jul 21
S-1/A
IPO registration (amended)
13 Jul 21
S-1
IPO registration
2 Jul 21
Other
EFFECT
Notice of effectiveness
23 Jul 21
CERT
Certification of approval for exchange listing
21 Jul 21
CORRESP
Correspondence with SEC
20 Jul 21
CORRESP
Correspondence with SEC
13 Jul 21
UPLOAD
Letter from SEC
12 Jul 21
CORRESP
Correspondence with SEC
2 Jul 21
UPLOAD
Letter from SEC
28 Jun 21
UPLOAD
Letter from SEC
18 May 21
Ownership
4
Ming Yan
11 Apr 24
144
Notice of proposed sale of securities
9 Apr 24
4
Philippe Busque
21 Mar 24
3
William D. McCombe
20 Mar 24
4
Ming Yan
19 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
4
Ming Yan
13 Mar 24
4
Paul Christopher Williams
13 Mar 24
4
Allen Poirson
13 Mar 24
4
Wenbin Jiang
13 Mar 24